2010-2012年我院抗糖尿病药物应用分析

目的:分析我院2010-2012年抗糖尿病药物的应用情况,为其合理用药提供依据。方法:对我院2010-2012年抗糖尿病药物的使用数据用Excel2003软件进行销售金额、用药频度(DDDs)、构成比、日均费用(DDC)等统计分析。结果:我院抗糖尿病药物的用药金额逐年稳定上升,DDDs排在前3位的为甘精胰岛素、瑞格列奈、精蛋白生物合成人胰岛素(预混30R);DDC排名前3位的为依帕司他、甘精胰岛素、精蛋白锌重组赖脯胰岛素混合注射液(25R)。结论:我院2010-2012年抗糖尿病药物的使用状况较为合理,非磺脲类促胰岛素分泌剂的选用倾向较大,口服新贵药和胰岛素制剂将会占据更大份额,临床应引起足够重视。

Use of anti-diabetic drugs of 2010-2012 in our hospital

Objective： To analyze use of anti-diabetic drugs in our hospital from 2010 through 2012 in order to provide some references for guiding and managing clinical use of anti-diabetic drugs.Methods： We analyzed consumption sum,defined daily dose（DDD）,DDDs,DDC and constituent ratio for antidiabetic drugs use.Results： The sales amount of anti-diabetic drugs was increasing steadily.The top 3 DDDs were insulin glargine injection,repaglinide tablets and isophane protamine biosynthetic human insulin injection（pre-mixed 30R）.The top 3 DDC were epalrestat tablets,insulin glargine injection and mixed protamine zinc recombinant human insulin lispro injection（25R）.Conclusion： The use of antidiabetic drugs was most rational in our hospital from 2010 to 2012.Non-sulfonylureas insulin secretagogues were often used in the clinic.The new,expensive oral drug and insulin preparations will occupy a larger market,and we should pay close attention to this in clinic.